Osborne Partners Capital Management »

Fate Therapeutics shares owned by Osborne Partners Capital Management

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Osborne Partners Capital Management from 13F filings

Historical chart of Osborne Partners Capital Management investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by Osborne Partners Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by Osborne Partners Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $13k 10k 1.26

More positions owned by Osborne Partners Capital Management

Vanguard Intl Equity Index F Allwrld Ex Us (VEU)
Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Msci Jpn Etf New (EWJ)
Vanguard Index Fds Real Estate Etf (VNQ)
Vanguard Intl Equity Index F Ftse Europe Etf (VGK)
NVIDIA Corporation (NVDA)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Spdr Index Shs Fds Dj Intl Rl Etf (RWX)
Ssga Active Etf Tr Blackstone Senr (SRLN)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Global X Fds Dax Germany Etf (DAX)

View all positions for Osborne Partners Capital Management

Top funds holding Fate Therapeutics

Redmile Group
BlackRock
Vanguard Group
Wilshire Associates
Johnson & Johnson
Acadian Asset Management
Geode Capital Management
Vestal Point Capital
Morgan Stanley
State Street Corporation
Dimensional Fund Advisors
Tang Capital Management
Goldman Sachs Group
Renaissance Technologies
AQR Capital Management

View all funds holding Fate Therapeutics